Carta Healthcare key facts
as of Oct 2026- Developer of a clinical data abstraction platform designed to improve the efficiency and quality of healthcare information management.
- Carta Healthcare is valued at approximately $80.0M as of Oct 2026 (last reported valuation).
- It has raised $60.5M; the latest was Later Stage VC ($18.3M) in May 2025.
- Notable investors include KB Investment, Alchemist Accelerator, Texas Medical Center, MaC Venture Capital, Maverick Ventures — 30 tracked in total.
- Status: Privately Held (backing).
Carta Healthcare's last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·The complete investor list: 30 names
- ·Watch Carta Healthcare: the Monday email on marks, rounds and moves
Carta Healthcare funding rounds
No funding rounds for Carta Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Carta Healthcare
30+Carta Healthcare valuation
Carta Healthcare's last reported valuation was $80 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Carta Healthcare investors
30 investors are on record for Carta Healthcare, including KB Investment, Alchemist Accelerator, Texas Medical Center and MaC Venture Capital. By type, the record holds 6 venture capital firms and 1 hedge fund.
About Carta Healthcare
Developer of a clinical data abstraction platform designed to improve the efficiency and quality of healthcare information management. The company's platform utilizes artificial intelligence to automate extraction and processing, reducing manual workload and enhancing accuracy, enabling hospitals and research organizations to optimize patient care, support compliance and improve operational decisions.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 106
- Website
- carta.healthcare/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.